172 related articles for article (PubMed ID: 28089453)
1. Serum uromodulin is a predictive biomarker for cardiovascular events and overall mortality in coronary patients.
Leiherer A; Muendlein A; Saely CH; Ebner J; Brandtner EM; Fraunberger P; Drexel H
Int J Cardiol; 2017 Mar; 231():6-12. PubMed ID: 28089453
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
[TBL] [Abstract][Full Text] [Related]
3. High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.
Saely CH; Leiherer A; Muendlein A; Vonbank A; Rein P; Geiger K; Malin C; Drexel H
Atherosclerosis; 2016 Jan; 244():38-43. PubMed ID: 26590865
[TBL] [Abstract][Full Text] [Related]
4. Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
Then C; Then HL; Lechner A; Thorand B; Meisinger C; Heier M; Peters A; Koenig W; Rathmann W; Scherberich J; Seissler J
Atherosclerosis; 2020 Mar; 297():1-7. PubMed ID: 32058862
[TBL] [Abstract][Full Text] [Related]
5. Data on the power of the creatinine to uromodulin ratio in serum to predict cardiovascular events in coronary patients.
Leiherer A; Muendlein A; Saely CH; Ebner J; Brandtner EM; Fraunberger P; Drexel H
Data Brief; 2017 Apr; 11():576-580. PubMed ID: 28861439
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of serial decline of kidney function to predict mortality and cardiovascular events in patients undergoing coronary angiography.
Rein P; Saely CH; Vonbank A; Boehnel C; Drexel H
Am J Cardiol; 2014 Jan; 113(2):215-21. PubMed ID: 24169005
[TBL] [Abstract][Full Text] [Related]
7. Serum Uromodulin and Mortality Risk in Patients Undergoing Coronary Angiography.
Delgado GE; Kleber ME; Scharnagl H; Krämer BK; März W; Scherberich JE
J Am Soc Nephrol; 2017 Jul; 28(7):2201-2210. PubMed ID: 28242751
[TBL] [Abstract][Full Text] [Related]
8. Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health Study.
Steubl D; Buzkova P; Garimella PS; Ix JH; Devarajan P; Bennett MR; Chaves PHM; Shlipak MG; Bansal N; Sarnak MJ
Nephrol Dial Transplant; 2020 Aug; 35(8):1399-1405. PubMed ID: 30903163
[TBL] [Abstract][Full Text] [Related]
9. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
[TBL] [Abstract][Full Text] [Related]
10. Serum uromodulin predicts graft failure in renal transplant recipients.
Steubl D; Block M; Herbst V; Schlumberger W; Nockher A; Angermann S; Schmaderer C; Heemann U; Renders L; Scherberich J
Biomarkers; 2017 Mar; 22(2):171-177. PubMed ID: 27790922
[TBL] [Abstract][Full Text] [Related]
11. Serum uromodulin and progression of kidney disease in patients with chronic kidney disease.
Lv L; Wang J; Gao B; Wu L; Wang F; Cui Z; He K; Zhang L; Chen M; Zhao MH
J Transl Med; 2018 Nov; 16(1):316. PubMed ID: 30454063
[TBL] [Abstract][Full Text] [Related]
12. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.
Kastrup J; Johansen JS; Winkel P; Hansen JF; Hildebrandt P; Jensen GB; Jespersen CM; Kjøller E; Kolmos HJ; Lind I; Nielsen H; Gluud C;
Eur Heart J; 2009 May; 30(9):1066-72. PubMed ID: 19270316
[TBL] [Abstract][Full Text] [Related]
13. Soluble low-density lipoprotein receptor-related protein 1 as a biomarker of coronary risk: Predictive capacity and association with clinical events.
de Gonzalo-Calvo D; Elosua R; Vea A; Subirana I; Sayols-Baixeras S; Marrugat J; Llorente-Cortés V
Atherosclerosis; 2019 Aug; 287():93-99. PubMed ID: 31247347
[TBL] [Abstract][Full Text] [Related]
14. The value of uromodulin as a new serum marker to predict decline in renal function.
Leiherer A; Muendlein A; Saely CH; Brandtner EM; Geiger K; Fraunberger P; Drexel H
J Hypertens; 2018 Jan; 36(1):110-118. PubMed ID: 28858977
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
[TBL] [Abstract][Full Text] [Related]
16. High betatrophin in coronary patients protects from cardiovascular events.
Leiherer A; Ebner J; Muendlein A; Brandtner EM; Zach C; Geiger K; Fraunberger P; Drexel H
Atherosclerosis; 2020 Jan; 293():62-68. PubMed ID: 31862484
[TBL] [Abstract][Full Text] [Related]
17. Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease.
Shlipak MG; Li Y; Fox C; Coresh J; Grunfeld C; Whooley M
BMC Nephrol; 2011 Jan; 12():2. PubMed ID: 21235779
[TBL] [Abstract][Full Text] [Related]
18. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
[TBL] [Abstract][Full Text] [Related]
19. Impact of the albumin to creatinine ratio and the coronary artery state on vascular events.
Rein P; Saely CH; Vonbank A; Fraunberger P; Drexel H
Am J Cardiol; 2014 May; 113(10):1616-20. PubMed ID: 24698462
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
